An Investigational Study of Cyclosporine on Experimental Medication BMS-986165 in Healthy Male Participants

• Status: Completed
• Trial end date: 2018-05-04
• Target enrollment: 0
• Participant gender: Male

Summary

This is an investigational study of Cyclosporine on the experimental medication BMS-986165 in healthy male participants.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Bristol-Myers Squibb
• Treatments: BMS-986165; Cyclosporine; Cyclosporins

Criteria

For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com

Inclusion Criteria:

• Healthy participant, as determined by no clinically significant deviation from normal in medical history, physical examination, ECGs, and clinical laboratory determinations

• Body mass index 18.0 to 32.0 kg/m2

• Weight ≥ 50 kg

Exclusion Criteria:

• Any medical condition that presents a potential risk to the subject and/or may compromise the objectives of the study, including a history of or active liver disease

• History or presence of acute or chronic bacterial, fungal, or viral infection (eg, pneumonia, septicemia) within the 3 months prior to screening

• Known or suspected autoimmune disorder, or any history of known or suspected congenital or acquired immunodeficiency state or condition that would compromise the participant's immune status

• History of administration of live vaccines within 60 days before screening

• Any history or risk for tuberculosis (TB)

Other protocol defined inclusion/exclusion criteria could apply